Hrt Financial LP Adamis Pharmaceuticals Corp Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.1 - $0.3 $13,067 - $39,201	130,673 Added 991.0%	143,859 $16,000
Q4 2022 Feb 10, 2023	BUY	$0.14 - $0.22 $1,846 - $2,900	13,186 New	13,186 $2,000
Q2 2022 Aug 12, 2022	BUY	$0.34 - $0.57 $9,259 - $15,523	27,235 New	27,235 $13,000
Q1 2022 May 16, 2022	SELL	$0.55 - $0.73 $11,726 - $15,564	-21,321 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.23 $12,152 - $26,224	21,321 New	21,321 $12,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.